Volume rendered 3D OCTA assessment of macular ischemia in patients with type 1 diabetes and without diabetic retinopathy

Abstract The aim of this study was to measure macular perfusion in patients with type 1 diabetes and no signs of diabetic retinopathy (DR) using volume rendered three-dimensional (3D) optical coherence tomography angiography (OCTA). We collected data from 35 patients with diabetes and no DR who had...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Enrico Borrelli, Domenico Grosso, Mariacristina Parravano, Eliana Costanzo, Maria Brambati, Chiara Viganò, Riccardo Sacconi, Lea Querques, Adelaide Pina, Daniele De Geronimo, Francesco Bandello, Giuseppe Querques
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/d9663c86ca0a4279abfbf2df5eda71c8
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:d9663c86ca0a4279abfbf2df5eda71c8
record_format dspace
spelling oai:doaj.org-article:d9663c86ca0a4279abfbf2df5eda71c82021-12-02T18:37:12ZVolume rendered 3D OCTA assessment of macular ischemia in patients with type 1 diabetes and without diabetic retinopathy10.1038/s41598-021-99297-72045-2322https://doaj.org/article/d9663c86ca0a4279abfbf2df5eda71c82021-10-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-99297-7https://doaj.org/toc/2045-2322Abstract The aim of this study was to measure macular perfusion in patients with type 1 diabetes and no signs of diabetic retinopathy (DR) using volume rendered three-dimensional (3D) optical coherence tomography angiography (OCTA). We collected data from 35 patients with diabetes and no DR who had OCTA obtained. An additional control group of 35 eyes from 35 healthy subjects was included for comparison. OCTA volume data were processed with a previously presented algorithm in order to obtain the 3D vascular volume and 3D perfusion density. In order to weigh the contribution of different plexuses’ impairment to volume rendered vascular perfusion, OCTA en face images were binarized in order to obtain two-dimensional (2D) perfusion density metrics. Mean ± SD age was 27.2 ± 10.2 years [range 19–64 years] in the diabetic group and 31.0 ± 11.4 years [range 19–61 years] in the control group (p = 0.145). The 3D vascular volume was 0.27 ± 0.05 mm3 in the diabetic group and 0.29 ± 0.04 mm3 in the control group (p = 0.020). The 3D perfusion density was 9.3 ± 1.6% and 10.3 ± 1.6% in diabetic patients and controls, respectively (p = 0.005). Using a 2D visualization, the perfusion density was lower in diabetic patients, but only at the deep vascular complex (DVC) level (38.9 ± 3.7% in diabetes and 41.0 ± 3.1% in controls, p = 0.001), while no differences were detected at the superficial capillary plexus (SCP) level (34.4 ± 3.1% and 34.3 ± 3.8% in the diabetic and healthy subjects, respectively, p = 0.899). In conclusion, eyes without signs of DR of patients with diabetes have a reduced volume rendered macular perfusion compared to control healthy eyes.Enrico BorrelliDomenico GrossoMariacristina ParravanoEliana CostanzoMaria BrambatiChiara ViganòRiccardo SacconiLea QuerquesAdelaide PinaDaniele De GeronimoFrancesco BandelloGiuseppe QuerquesNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Enrico Borrelli
Domenico Grosso
Mariacristina Parravano
Eliana Costanzo
Maria Brambati
Chiara Viganò
Riccardo Sacconi
Lea Querques
Adelaide Pina
Daniele De Geronimo
Francesco Bandello
Giuseppe Querques
Volume rendered 3D OCTA assessment of macular ischemia in patients with type 1 diabetes and without diabetic retinopathy
description Abstract The aim of this study was to measure macular perfusion in patients with type 1 diabetes and no signs of diabetic retinopathy (DR) using volume rendered three-dimensional (3D) optical coherence tomography angiography (OCTA). We collected data from 35 patients with diabetes and no DR who had OCTA obtained. An additional control group of 35 eyes from 35 healthy subjects was included for comparison. OCTA volume data were processed with a previously presented algorithm in order to obtain the 3D vascular volume and 3D perfusion density. In order to weigh the contribution of different plexuses’ impairment to volume rendered vascular perfusion, OCTA en face images were binarized in order to obtain two-dimensional (2D) perfusion density metrics. Mean ± SD age was 27.2 ± 10.2 years [range 19–64 years] in the diabetic group and 31.0 ± 11.4 years [range 19–61 years] in the control group (p = 0.145). The 3D vascular volume was 0.27 ± 0.05 mm3 in the diabetic group and 0.29 ± 0.04 mm3 in the control group (p = 0.020). The 3D perfusion density was 9.3 ± 1.6% and 10.3 ± 1.6% in diabetic patients and controls, respectively (p = 0.005). Using a 2D visualization, the perfusion density was lower in diabetic patients, but only at the deep vascular complex (DVC) level (38.9 ± 3.7% in diabetes and 41.0 ± 3.1% in controls, p = 0.001), while no differences were detected at the superficial capillary plexus (SCP) level (34.4 ± 3.1% and 34.3 ± 3.8% in the diabetic and healthy subjects, respectively, p = 0.899). In conclusion, eyes without signs of DR of patients with diabetes have a reduced volume rendered macular perfusion compared to control healthy eyes.
format article
author Enrico Borrelli
Domenico Grosso
Mariacristina Parravano
Eliana Costanzo
Maria Brambati
Chiara Viganò
Riccardo Sacconi
Lea Querques
Adelaide Pina
Daniele De Geronimo
Francesco Bandello
Giuseppe Querques
author_facet Enrico Borrelli
Domenico Grosso
Mariacristina Parravano
Eliana Costanzo
Maria Brambati
Chiara Viganò
Riccardo Sacconi
Lea Querques
Adelaide Pina
Daniele De Geronimo
Francesco Bandello
Giuseppe Querques
author_sort Enrico Borrelli
title Volume rendered 3D OCTA assessment of macular ischemia in patients with type 1 diabetes and without diabetic retinopathy
title_short Volume rendered 3D OCTA assessment of macular ischemia in patients with type 1 diabetes and without diabetic retinopathy
title_full Volume rendered 3D OCTA assessment of macular ischemia in patients with type 1 diabetes and without diabetic retinopathy
title_fullStr Volume rendered 3D OCTA assessment of macular ischemia in patients with type 1 diabetes and without diabetic retinopathy
title_full_unstemmed Volume rendered 3D OCTA assessment of macular ischemia in patients with type 1 diabetes and without diabetic retinopathy
title_sort volume rendered 3d octa assessment of macular ischemia in patients with type 1 diabetes and without diabetic retinopathy
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/d9663c86ca0a4279abfbf2df5eda71c8
work_keys_str_mv AT enricoborrelli volumerendered3doctaassessmentofmacularischemiainpatientswithtype1diabetesandwithoutdiabeticretinopathy
AT domenicogrosso volumerendered3doctaassessmentofmacularischemiainpatientswithtype1diabetesandwithoutdiabeticretinopathy
AT mariacristinaparravano volumerendered3doctaassessmentofmacularischemiainpatientswithtype1diabetesandwithoutdiabeticretinopathy
AT elianacostanzo volumerendered3doctaassessmentofmacularischemiainpatientswithtype1diabetesandwithoutdiabeticretinopathy
AT mariabrambati volumerendered3doctaassessmentofmacularischemiainpatientswithtype1diabetesandwithoutdiabeticretinopathy
AT chiaravigano volumerendered3doctaassessmentofmacularischemiainpatientswithtype1diabetesandwithoutdiabeticretinopathy
AT riccardosacconi volumerendered3doctaassessmentofmacularischemiainpatientswithtype1diabetesandwithoutdiabeticretinopathy
AT leaquerques volumerendered3doctaassessmentofmacularischemiainpatientswithtype1diabetesandwithoutdiabeticretinopathy
AT adelaidepina volumerendered3doctaassessmentofmacularischemiainpatientswithtype1diabetesandwithoutdiabeticretinopathy
AT danieledegeronimo volumerendered3doctaassessmentofmacularischemiainpatientswithtype1diabetesandwithoutdiabeticretinopathy
AT francescobandello volumerendered3doctaassessmentofmacularischemiainpatientswithtype1diabetesandwithoutdiabeticretinopathy
AT giuseppequerques volumerendered3doctaassessmentofmacularischemiainpatientswithtype1diabetesandwithoutdiabeticretinopathy
_version_ 1718377830463569920